Format
Sort by
Items per page

Send to

Choose Destination

Best matches for cannabidiol and energy metabolism:

Search results

Items: 1 to 20 of 39

1.

Cannabidiol administration reduces sublesional cancellous bone loss in rats with severe spinal cord injury.

Li D, Lin Z, Meng Q, Wang K, Wu J, Yan H.

Eur J Pharmacol. 2017 Aug 15;809:13-19. doi: 10.1016/j.ejphar.2017.05.011. Epub 2017 May 4.

PMID:
28479140
2.

Effects of a Sativex-Like Combination of Phytocannabinoids on Disease Progression in R6/2 Mice, an Experimental Model of Huntington's Disease.

Valdeolivas S, Sagredo O, Delgado M, Pozo MA, Fernández-Ruiz J.

Int J Mol Sci. 2017 Mar 23;18(4). pii: E684. doi: 10.3390/ijms18040684.

3.
4.

Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome.

Reuter SE, Martin JH.

Clin Pharmacokinet. 2016 Jul;55(7):807-812. doi: 10.1007/s40262-015-0363-2. Review.

PMID:
26883879
5.

Role of the endocannabinoid system in diabetes and diabetic complications.

Gruden G, Barutta F, Kunos G, Pacher P.

Br J Pharmacol. 2016 Apr;173(7):1116-27. doi: 10.1111/bph.13226. Epub 2015 Aug 20. Review.

6.

Relationship between seminal plasma levels of anandamide congeners palmitoylethanolamide and oleoylethanolamide and semen quality.

Amoako AA, Marczylo TH, Elson J, Taylor AH, Willets JM, Konje JC.

Fertil Steril. 2014 Nov;102(5):1260-7. doi: 10.1016/j.fertnstert.2014.07.767. Epub 2014 Sep 8.

PMID:
25212838
7.

Cannabinoid-induced changes in respiration of brain mitochondria.

Fišar Z, Singh N, Hroudová J.

Toxicol Lett. 2014 Nov 18;231(1):62-71. doi: 10.1016/j.toxlet.2014.09.002. Epub 2014 Sep 6.

PMID:
25195527
8.

Cannabidiol Exposure During Neuronal Differentiation Sensitizes Cells Against Redox-Active Neurotoxins.

Schönhofen P, de Medeiros LM, Bristot IJ, Lopes FM, De Bastiani MA, Kapczinski F, Crippa JA, Castro MA, Parsons RB, Klamt F.

Mol Neurobiol. 2015 Aug;52(1):26-37. doi: 10.1007/s12035-014-8843-1. Epub 2014 Aug 10.

PMID:
25108670
9.

Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.

Laprairie RB, Bagher AM, Kelly ME, Dupré DJ, Denovan-Wright EM.

J Biol Chem. 2014 Sep 5;289(36):24845-62. doi: 10.1074/jbc.M114.557025. Epub 2014 Jul 18.

10.

Acute and chronic administration of cannabidiol increases mitochondrial complex and creatine kinase activity in the rat brain.

Valvassori SS, Bavaresco DV, Scaini G, Varela RB, Streck EL, Chagas MH, Hallak JE, Zuardi AW, Crippa JA, Quevedo J.

Braz J Psychiatry. 2013 Oct-Dec;35(4):380-6. doi: 10.1590/1516-4446-2012-0886. Epub 2013 Dec 23.

11.

Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death.

Rimmerman N, Ben-Hail D, Porat Z, Juknat A, Kozela E, Daniels MP, Connelly PS, Leishman E, Bradshaw HB, Shoshan-Barmatz V, Vogel Z.

Cell Death Dis. 2013 Dec 5;4:e949. doi: 10.1038/cddis.2013.471.

12.

The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2.

Morelli MB, Offidani M, Alesiani F, Discepoli G, Liberati S, Olivieri A, Santoni M, Santoni G, Leoni P, Nabissi M.

Int J Cancer. 2014 Jun 1;134(11):2534-46. doi: 10.1002/ijc.28591. Epub 2013 Dec 2.

13.

Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implications for neuroprotection.

da Silva VK, de Freitas BS, da Silva Dornelles A, Nery LR, Falavigna L, Ferreira RD, Bogo MR, Hallak JE, Zuardi AW, Crippa JA, Schröder N.

Mol Neurobiol. 2014 Feb;49(1):222-33. doi: 10.1007/s12035-013-8514-7. Epub 2013 Jul 28.

PMID:
23893294
14.

Cannabinoids and schizophrenia: therapeutic prospects.

Robson PJ, Guy GW, Di Marzo V.

Curr Pharm Des. 2014;20(13):2194-204. Review.

PMID:
23829368
15.

Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT(1A) and CB2 receptors.

Pazos MR, Mohammed N, Lafuente H, Santos M, Martínez-Pinilla E, Moreno E, Valdizan E, Romero J, Pazos A, Franco R, Hillard CJ, Alvarez FJ, Martínez-Orgado J.

Neuropharmacology. 2013 Aug;71:282-91. doi: 10.1016/j.neuropharm.2013.03.027. Epub 2013 Apr 12.

PMID:
23587650
16.

Endocannabinoids in nervous system health and disease: the big picture in a nutshell.

Skaper SD, Di Marzo V.

Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3193-200. doi: 10.1098/rstb.2012.0313.

17.

A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis.

Granja AG, Carrillo-Salinas F, Pagani A, Gómez-Cañas M, Negri R, Navarrete C, Mecha M, Mestre L, Fiebich BL, Cantarero I, Calzado MA, Bellido ML, Fernandez-Ruiz J, Appendino G, Guaza C, Muñoz E.

J Neuroimmune Pharmacol. 2012 Dec;7(4):1002-16. doi: 10.1007/s11481-012-9399-3. Epub 2012 Sep 14.

PMID:
22971837
18.

Contrasting protective effects of cannabinoids against oxidative stress and amyloid-β evoked neurotoxicity in vitro.

Harvey BS, Ohlsson KS, Mååg JL, Musgrave IF, Smid SD.

Neurotoxicology. 2012 Jan;33(1):138-46. doi: 10.1016/j.neuro.2011.12.015. Epub 2012 Jan 3.

PMID:
22233683
19.

Cannabidiol-2',6'-dimethyl ether as an effective protector of 15-lipoxygenase-mediated low-density lipoprotein oxidation in vitro.

Takeda S, Hirayama A, Urata S, Mano N, Fukagawa K, Imamura M, Irii A, Kitajima S, Masuyama T, Nomiyama M, Tatei S, Tomita S, Kudo T, Noguchi M, Yamaguchi Y, Okamoto Y, Amamoto T, Fukunishi Y, Watanabe K, Omiecinski CJ, Aramaki H.

Biol Pharm Bull. 2011;34(8):1252-6.

20.

Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes.

Jiang R, Yamaori S, Takeda S, Yamamoto I, Watanabe K.

Life Sci. 2011 Aug 1;89(5-6):165-70. doi: 10.1016/j.lfs.2011.05.018. Epub 2011 Jun 16.

PMID:
21704641

Supplemental Content

Loading ...
Support Center